Joint review of HIV, TB and PMTCT programmes in South Africa

National Department of Health

The National Department of Health (NDOH) commissioned a Joint Review of the HIV, TB and PMTCT Programmes to be undertaken in 2013. The main purpose of this independent Review, carried out by a multi-disciplinary team of South African and international reviewers, was to assess performance of the programmes and provide options for improvement. The focus of the Joint Review was on issues critical to effective delivery and impact of HIV, TB and PMTCT services - to assess progress made, identify challenges, and highlight best practices. The Review was also to recommend strategic and operational approaches for further scale-up, improvement of quality and increasing value for money of key HIV, TB and PMTCT services. 

The objectives of the Review were as follows: 

1. To review progress and capacity requirements towards reaching national health sector targets for HIV and TB. 

2. To review the level of integration of management and services between HIV and TB programmes at all levels. 

3. To assess quality and effectiveness of HIV and TB services and the extent to which previous reviews and emerging science are incorporated into delivery of HIV and TB services. 

4. To assess existing capacities and challenges and propose options for further strengthening of cross-cutting systems for service delivery such as supply chain, information systems, laboratory and health workforce. 

5. To analyse current investments, value for money and investment priorities in the short and medium term for the TB and HIV programmes. 

Overall strategic guidance to and oversight of the Review was provided by a Steering Committee chaired by the National Department of Health in which a wide range of national stakeholders and development partners were also represented.

May 21, 2014
Year of publication
Resource types
Reports and Fact sheets
HIV programmes, TB programmes, PMTCT programmes, HIV, TB, PMTCT

Similar Resources

Timely access to antiretroviral treatment (ART) is vital to ensuring safe motherhood and reducing vertical transmission. Treatment guidance and programming has changed dramatically in recent years.

Many countries are working to reduce or eliminate mother-to-child transmission (MTCT) of HIV. Prevention efforts have been conceptualized as steps in a cascade but cascade completion rates during and after pregnancy are low.

This paper documents the development of the global and national monitoring and reporting systems for PMTCT and paediatric HIV care and treatment programmes, achievements and remaining challenges.

Option B+ for prevention of mother-to-child transmission (PMTCT) specifies treating all HIV-positive women with antiretroviral therapy (ART) regardless of CD4 count. This simplified approach enhances countries' capacity to reach national HIV targets and contribute to the global 90-90-90 goals.…

This report compiles the latest body of evidence on how stigma and discrimination create barriers across the HIV prevention, testing and treatment cascades and reduce the impact of the AIDS response.

In 2013, Uganda updated its prevention of maternal-to-child transmission of HIV program to Option B+, which requires that all HIV-infected pregnant and breastfeeding women be started on lifelong antiretroviral therapy (ART) regardless of CD4 count…

An essential first step in caring for HIV-infected children is accurate and early diagnosis of HIV, early HIV testing, prompt return of results, and rapid initiation of treatment.

The Partnership for HIV-Free Survival (PHFS) was designed to use basic quality improvement practices to reduce mother-to-child transmission of HIV and increase child survival through improvements in (1) antiretroviral therapy uptake and retention among HIV-positive pregnant women and mothers, (2)

Angola has a generalized, heterosexually-driven HIV epidemic with an adult prevalence of 2.42 percent, according to 2014 estimates from the Joint United Nations Programme on HIV/AIDS (UNAIDS 2014a).